Drugs for inflammatory conditions drove nearly half of spending in commercial plans last year, a new report shows. Express Scripts released its annual Drug Trend Report, which analyzes costs and spending for 33.6 million members enrolled in one of its ...

A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.

The federal government has backed off a proposal that would have let Medicare Part D prescription drug plans deny coverage for therapies in six "protected" classes of drugs, including those for cancer and psychiatric conditions. While that is seen as a win ...

The Biden administration has walked back a last-minute bid by its predecessor to give Part D plans the ability to restrict access to certain classes of drugs such as antidepressants. The Centers for Medicare & Medicaid Services announced a change on late ...

This study analyzes 20 years of data from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) to reveal trends in drug-induced fatty liver disease (DIFLD), identifying high-risk drug classes and vulnerable populations,

The US Food and Drug Administration (FDA) has added 25 drugs or drug classes to its quarterly list of agents in which it has found a potential sign of serious risk or new safety information. The new list, created from the FDA Adverse Event Reporting System ...

Credit: Getty Images In an unexpected finding, phosphodiesterase inhibitors and sympathomimetics with α- and β-effect were strongly associated with higher AKI risk in this analysis. High AKI risk was found among critically ill patients treated with known ...

Two new classes of HIV drugs are poised to hit the market in 2007, signalling what many say is a watershed in HIV treatment, second only to the introduction of cocktail therapy more than a decade ago. The new drugs — Pfizer's maraviroc and Merck's ...

Please provide your email address to receive an email when new articles are posted on . The thiazolidinedione pioglitazone and GLP-1 receptor agonists are the only two diabetes drugs proved to increase and maintain beta-cell function, and both should be ...